- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Finch Therapeutics Group Inc is a biotechnology business based in the US. Finch Therapeutics Group Inc shares (FNCH) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $10.40 – a decrease of 13.33% over the previous week. Finch Therapeutics Group Inc employs 1 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
- FNCH shares summary
- Compare share dealing platforms
- Is FNCH stock a buy or sell?
- Stock performance over time
- Can I short FNCH shares?
- Finch Therapeutics Group Inc's financials
- How volatile are FNCH shares?
- Does Finch Therapeutics Group Inc pay a dividend?
- Have FNCH shares ever split?
- Other common questions
Our top picks for where to buy Finch Therapeutics Group stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Finch Therapeutics Group Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – FNCH. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Finch Therapeutics Group Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Finch Therapeutics Group Inc stock price (PINK: FNCH)
Use our graph to track the performance of FNCH stocks over time.Finch Therapeutics Group Inc shares at a glance
Information last updated 2024-12-19.
| Latest market close | $10.40 |
|---|---|
| 52-week range | $0.80 - $14.26 |
| 50-day moving average | $11.77 |
| 200-day moving average | $6.40 |
| Wall St. target price | $90.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-8.80 |
Finch Therapeutics Group Inc price performance over time
Historical closes compared with the close of $11.3 from 2024-12-17
| 1 week (2024-12-13) | -5.83% |
|---|---|
| 1 month (2024-11-20) | -1.31% |
| 3 months (2024-09-20) | -0.88% |
| 6 months (2024-06-20) | 730.88% |
| 1 year (2023-12-20) | 280.47% |
|---|---|
| 2 years (2022-12-20) | -35.44% |
| 3 years (2021-12-20) | 290.4 |
| 5 years (2019-12-16) | N/A |
Finch Therapeutics Group Inc financials
| Gross profit TTM | $-57,032,000 |
|---|---|
| Return on assets TTM | -21.89% |
| Return on equity TTM | -67.28% |
| Profit margin | 0% |
| Book value | $8.86 |
| Market Capitalization | $18.1 million |
TTM: trailing 12 months
Finch Therapeutics Group Inc share dividends
We're not expecting Finch Therapeutics Group Inc to pay a dividend over the next 12 months.
You may also wish to consider:
Have Finch Therapeutics Group Inc's shares ever split?
Finch Therapeutics Group Inc's shares were split on a 1:30 basis on 11 June 2023 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Finch Therapeutics Group Inc shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Finch Therapeutics Group Inc shares which in turn could have impacted Finch Therapeutics Group Inc's share price.
Finch Therapeutics Group Inc share price volatility
Over the last 12 months, Finch Therapeutics Group Inc's shares have ranged in value from as little as $0.8 up to $14.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Finch Therapeutics Group Inc's is 1.335. This would suggest that Finch Therapeutics Group Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Finch Therapeutics Group Inc's beta into context you can compare it against those of similar companies.
- Catalyst Pharmaceuticals (CPRX.US): 0.755
- BioDelivery Sciences International (BDSI.US): 0.5551
- Trillium Therapeutics (TRIL.US): 1.9046
Finch Therapeutics Group Inc overview
Finch Therapeutics Group, Inc. , a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts. .
Frequently asked questions
nullWhat percentage of Finch Therapeutics Group Inc is owned by insiders or institutions?
Currently 53.457% of Finch Therapeutics Group Inc shares are held by insiders and 3.31% by institutions. How many people work for Finch Therapeutics Group Inc?
Latest data suggests 1 work at Finch Therapeutics Group Inc. When does the fiscal year end for Finch Therapeutics Group Inc?
Finch Therapeutics Group Inc's fiscal year ends in December. Where is Finch Therapeutics Group Inc based?
Finch Therapeutics Group Inc's address is: 75 State Street, Boston, MA, United States, 02109 What is Finch Therapeutics Group Inc's ISIN number?
Finch Therapeutics Group Inc's international securities identification number is: US31773D1019
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question